Search The Medical Knowledge Base
Medical News by Category
Breast Cancer News
- Early success for CDX 011 (Celldex) in Phase II Breast Cancer study
Published: Thursday 24 May 2012
- NICE rejects Avastin/Xeloda (Roche) combination for Breast Cancer
Published: Wednesday 18 April 2012
- Valeant Pharma to market Halaven for Breast Cancer in Eastern Europe
Published: Tuesday 10 April 2012
- Entinostat (Syndax/GSK) enetrs Phase I/II trial for Breast Cancer
Published: Tuesday 10 April 2012
- NICE rejects Halaven (Eisai) for Breast Cancer
Published: Tuesday 03 April 2012
- Genentech reports successful EMILIA study results for T-DMI for HER-2 Breast Cancer
Published: Friday 30 March 2012
- BOLERO-2 trail shows bonbe improvement with Afinitor/Aromasin combination in Breast Cancer
Published: Wednesday 28 March 2012
- Mammaprint genomic test (Agendia) spares Breast Cancer patients chemotherapy with no adverse effect on survival
Published: Saturday 24 March 2012
- FDA approves Inform HER2 Dual ISH DNA Probe cocktail assay (Ventana MS) as Breast Cancer assay
Published: Saturday 03 March 2012
- NICE rejects Tyverb (GSK) as first line treatment of Post Menopausal Breast Cancer
Published: Tuesday 14 February 2012
- NICE rejects Herceptin (Roche) as first line treatment for Post Menopausal Breast Cancer
Published: Tuesday 14 February 2012
- Combining 2 anti-HER2 drugs may provide better preoperative breast cancer treatment
Published: Wednesday 18 January 2012
- Herceptin (Roche) may equalise DFS for obese and normal weight Breast Cancer patients
Published: Tuesday 13 December 2011
- Omnitarg (Genentech/Roche ) success in CLEOPATRA trial in untreated HER-2 positive Breast Cancer
Published: Monday 12 December 2011
- Why women with Breast Cancer quit aromatase therapy
Published: Monday 12 December 2011
- Zometa (Novartis) shows clear benefits for premenopausal ER-Positive Breast Cancer patients
Published: Sunday 11 December 2011
- Aromasin (Pfizer) found to lower 'good' cholesterol levels in Breast Cancer patients
Published: Sunday 11 December 2011
- Zometa (Novartis) with endocrine therapy improves survival in post menopausal Breast Cancer patients
Published: Saturday 10 December 2011
- Tyverb (GSK) disappoints in HER2 positive Breast Cancer
Published: Friday 09 December 2011
- Addition of Avastin (Genentech) to conventional therapy improves survival in HER2-positive Breast Cancer
Published: Friday 09 December 2011
- Exemestane plus Afinitor (Novartis) increased progression-free survival for Breast Cancer patients
Published: Friday 09 December 2011
- Omnitarg (Genentech/Roche) success in Phase II Breast Cancer trial in combination with Herceptin and chemotherapy
Published: Thursday 08 December 2011
- FDA withdraws approval of Avastin (Genentech) for Breast Cancer patients
Published: Saturday 19 November 2011
- Switching from tamoxifen to Aromasin improves Breast Cancer survival rate
Published: Wednesday 02 November 2011
- Femara offers significant advantages over tamoxifen for Breast Cancer patients
Published: Saturday 22 October 2011
- Subcutaneous Herceptin trial reveals benefits for Breast Cancer patients
Published: Thursday 20 October 2011
- Zometa prevents bone loss side effects of Breast Cancer medication
Published: Tuesday 11 October 2011
- Puma Biotechnology licenses neratinib for Breast Cancer from Pfizer
Published: Friday 07 October 2011
- FDA issues warnings on Avastin
Published: Friday 07 October 2011
- Early stage Breast Cancer benefit from Herceptin and chemotherapy
Published: Friday 07 October 2011
- BOLERO-2 study of Afinitor in ER+HER-2 advanced Breast Cancer is presented at EMCC congress
Published: Thursday 29 September 2011
- BOLERO-2 study of Afinitor in ER+HER-2 advanced Breast Cancer is presented at EMCC Congress
Published: Wednesday 28 September 2011
- Zometa reduces risk of Breast Cancer recurrence in post-menopausal patients
Published: Tuesday 27 September 2011
- Afinitor success in BOLERO 2 study in advanced Breast Cancer
Published: Wednesday 06 July 2011